Velasco A, Vongpatanasin W. The evaluation and treatment of endocrine forms of hypertension[J]. Curr Cardiol Rep, 2014, 16(9): 528. [2]Ducher M, Mounier-Vehier C, Baguet J P, et al. Aldosterone-to-renin ratio for diagnosing aldosterone-producing adenoma:？ a multicentre study[J]. Arch Cardiovasc Dis, 2012, 105(12): 623-630. [3]徐嫒媛, 蒋怡然, 苏？为, 等. 醛固酮/肾素比值在原发性醛固酮增多症筛查中的临床价值[J]. 中华内分泌代谢杂志, 2012, 28(4): 301-305. [4]Savard S, Amar L, Plouin P F, et al. Cardiovascular complications associated with primary aldosteronism:？ a controlled cross-sectional study[J]. Hypertension, 2013, 62(2):？ 331-336. [5]Milliez P, Girerd X, Plouin P F, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism[J]. J Am Coll Cardiol, 2005, 45(8):？ 1243-1248. [6]Turchi F, Ronconi V, di-Tizio V, et al. Primary aldosteronism and essential hypertension:？ assessment of cardiovascular risk at diagnosis and after treatment[J]. Nutr Metab Cardiovasc Dis, 2014, 24(5): 476-482. [7]Stehr C B, Mellado R, Ocaranza M P, et al. Increased levels of oxidative stress, subclinical inflammation, and myocardial fibrosis markers in primary aldosteronism patients[J]. J Hypertens, 2010, 28(10):？ 2120- 2126. [8]Bernini G, Galetta F, Franzoni F, et al. Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism[J]. J Hypertens, 2008, 26(12): 2399-2405. [9]Jansen P M, van-den-Born B H, Frenkel W J, et al. Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism[J]. J Hypertens, 2014, 32(1): 115-126. [10]中国高血压防治指南修订委员会. 中国高血压防治指南2010[J]. 中华高血压杂志, 2011, 19(8): 701-743. [11]Quinkler M, Stewart P M. Treatment of primary aldosteronism [J]. Best Pract Res Clin Endocrinol Metab, 2010, 24(6): 923-932. [12]Chen W, Li F, He C, et al. Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism:？ a meta-analysis[J]. Ir J Med Sci, 2014, 183(2):？ 283-291. [13]Mulatero P, Stowasser M, Loh K C, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents[J]. J Clin Endocrinol Metab, 2004, 89(3):？ 1045-1050. [14]Rios M C, Izquierdo A, Sotelo M, et al. Aldosterone/renin ratio in the diagnosis of primary aldosteronism[J]. Medicina (B Aires), 2011, 71(6):？ 525-530. [15]Lin Y H, Wu X M, Lee H H, et al. Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism[J]. J Hypertens, 2012, 30(8):？ 1606-1613.
[2]
李源,陈彩宇,杨剑,等.多巴胺D3受体对醛固酮介导的血管平滑肌细胞增殖的影响[J].第三军医大学学报,2013,35(10):943. Li Yuan,Chen Caiyu,Yang Jian,et al.D3 dopamine receptor suppresses aldosterone-induced proliferation of vascular smooth muscle cells[J].J Third Mil Med Univ,2013,35(11):943.
